Aeonmed Medical Treatment
VC Fund
Beijing, China
Aeonmed Medical Treatment (至尊租车) is a manufacturer and supplier of operating theatre and ICU devices, and medical treatment system solutions.Since its foundation, Aeonmed has always been guided by the clinical demands, and dedicated to the study of clinical medical equipment and solutions. Now, Aeonmed business covers three major productportfolios, including anesthesia and operation support, emergency and critical care and medical engineering equipment, and five major medical system solutions including laminar flow monitoring, environment and equipment configuration, centralized gas supply, process quality control and information integration.Currently, Aeon has more than 600 authorized and declared patents, among which there are more than 400 patents for invention, maintaining an increase of over 100 patents each year.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 60%
Last updated:
For AI agents: llms.txt
Industries Aeonmed Medical Treatment invests in
Stages Aeonmed Medical Treatment invests in
Countries Aeonmed Medical Treatment invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Changying Li
|
|||
Investment Focus
Industry
- Medical 2 (40%)
- Software 2 (40%)
- Health Care 2 (40%)
- Biotechnology 1 (20%)
- Manufacturing 1 (20%)
Stage
- Series A 2 (40%)
- Angel 1 (20%)
- Corporate Round 1 (20%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Changying Li
President
|
President | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Kunlunyuan
|
Kunlunyuan offers full-stack technology services for AI big models. It is involved in the research and development of technologies such as native fundamental big models, multimodal big models, AI operating systems. | $4.3M / Angel / Dec 29, 2025 | |
Eulon Robotics
|
Eulon Robotics is a high-tech company specializing in the development of advanced rehabilitation technologies, particularly focusing on intelligent rehabilitation through exoskeleton robots and peripheral rehabilitation devices. The company integrates independent research and development (R&D), large-scale production, and market sales ofmedical exoskeletons and related rehabilitation robots | Corporate Round / Dec 26, 2025 | |
Curegene
|
Curegene focuses on the treatment of anti-viral diseases as well as cardiovascular and cerebrovascular diseases. The company has made strides in the development of small molecules and nucleic acid pharmaceuticals and currently possesses the most advanced targeted prodrug and nucleic acid drug technology platforms. | Series B / Oct 31, 2024 | |
Genewise Bio
|
Genewise Bio is a biotechnology company that specializes in the technological iteration of POCT in molecular diagnostics. | $14.1M / Series A / Jun 04, 2024 | |
Casibrain Technology
|
Casibrain Technology is a medical device enterprise that has grown up from the Institute of Automation. | Series A / Jan 30, 2024 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Aeonmed Medical Treatment invest in?
Aeonmed Medical Treatment invests primarily in Medical, Software and Health Care startups, most often at Series A and Angel stage. Most of the 5 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Aeonmed Medical Treatment?
Public channels for Aeonmed Medical Treatment include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Aeonmed Medical Treatment?
The team at Aeonmed Medical Treatment includes Changying Li (President). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
